UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 365

Sortiert nach

Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma

Thoracic cancer, 2016-03, Vol.7 (2), p.222-225

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status

Zhōnghuá zhŏngliú zázhì, 2012-10, Vol.34 (10), p.780

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients

Zhōnghuá zhŏngliú zázhì, 2007-04, Vol.29 (4), p.298

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer

Zhong hua yi xue za zhi, 2012-06, Vol.92 (22), p.1527-1531

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting the sensitivity of EGFR-TKI treatment in advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2011-03, Vol.33 (3), p.217

2011

Link zum Volltext

Verfügbarkeit prüfen

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

Thoracic cancer, 2015-09, Vol.6 (5), p.636-642

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer

Chinese journal of cancer research, 2013-04, Vol.25 (2), p.200-205

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of serum EGFR protein concentration with the efficacy of Gefitinib in the treatment of advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2011-06, Vol.33 (6), p.431

2011

Link zum Volltext

Verfügbarkeit prüfen

Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2011-02, Vol.33 (2), p.142

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of chemotherapeutic efficacy after a failed regimen of epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced non-small cell lung carcinoma

Zhong hua yi xue za zhi, 2011-02, Vol.91 (6), p.366-369

2011

Link zum Volltext

Verfügbarkeit prüfen

Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2007-07, Vol.29 (7), p.549

2007

Link zum Volltext

Verfügbarkeit prüfen

A late Eocene palynological record from the Nangqian Basin, Tibetan Plateau: Implications for stratigraphy and paleoclimate

Palaeoworld, 2017-06, Vol.26 (2), p.369-379

2017

Link zum Volltext

Verfügbarkeit prüfen

XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2006-03, Vol.28 (3), p.196

2006

Link zum Volltext

Verfügbarkeit prüfen

Sequential administration of gefitinib and docetaxel as second-line therapy for advanced non-small cell lung cancer: analysis of 82 cases

Zhong hua yi xue za zhi, 2008-08, Vol.88 (32), p.2258-2262

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2004-06, Vol.26 (6), p.369

2004

Link zum Volltext

Verfügbarkeit prüfen

Combined modality therapy for small cell lung cancer patient with limited stage disease

Zhōnghuá zhŏngliú zázhì, 2007-09, Vol.29 (9), p.701

2007

Link zum Volltext

Verfügbarkeit prüfen

Establishment of a model to assess the clinical efficacy of Gefitinib in treatment of non-small cell lung cancer

Zhong hua yi xue za zhi, 2007-11, Vol.87 (43), p.3069-3073

2007

Link zum Volltext

Verfügbarkeit prüfen

IRESSA in the treatment of advanced non-small-cell lung cancer patients who failed to respond previous chemotherapy

Zhōnghuá zhŏngliú zázhì, 2004-12, Vol.26 (12), p.742

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer

Zhōngguó yīxué kēxuéyuàn xuébào, 2014-06, Vol.36 (3), p.305

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms

Zhōnghuá zhŏngliú zázhì, 2006-02, Vol.28 (2), p.107

2006

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2006-10, Vol.28 (10), p.777

2006

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy

Zhōnghuá zhŏngliú zázhì, 2008-06, Vol.30 (6), p.465

2008

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2005-12, Vol.27 (12), p.743

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2006-04, Vol.28 (4), p.309

2006

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel in the treatment of advanced breast cancer

Zhōnghuá zhŏngliú zázhì, 2006-06, Vol.28 (6), p.468

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(301)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma

Efficacy of erlotinib after the failure of gefitinib in patients with metastasis of non-small cell lung cancer with unknown EGFR mutation status

Clinical characteristics and chemotherapy of advanced-stage bronchioloalveolar carcinoma of the lung: report of 53 patients

Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer

Factors affecting the sensitivity of EGFR-TKI treatment in advanced non-small cell lung cancer

Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

Efficacy and safety of albumin-bound paclitaxel in treating recurrent advanced non-small-cell lung cancer

Association of serum EGFR protein concentration with the efficacy of Gefitinib in the treatment of advanced non-small cell lung cancer

Thoracic radiation therapy improves the prognosis for patients with extensive stage small-cell lung cancer

Analysis of chemotherapeutic efficacy after a failed regimen of epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced non-small cell lung carcinoma

Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer

A late Eocene palynological record from the Nangqian Basin, Tibetan Plateau: Implications for stratigraphy and paleoclimate

XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer

Sequential administration of gefitinib and docetaxel as second-line therapy for advanced non-small cell lung cancer: analysis of 82 cases

Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer

Combined modality therapy for small cell lung cancer patient with limited stage disease

Establishment of a model to assess the clinical efficacy of Gefitinib in treatment of non-small cell lung cancer

IRESSA in the treatment of advanced non-small-cell lung cancer patients who failed to respond previous chemotherapy

Comparison of efficacy and safety between liposome-paclitaxel injection plus carboplatin and paclitaxel plus carboplatin as first line treatment in advanced non-small cell lung cancer

Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms

Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer

A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy

A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer

Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer

Docetaxel in the treatment of advanced breast cancer

Suchergebnisse filtern